Legal Opinion
Eagle Pharm., Inc. v. Slayback Pharma LLC
District Court, D. Delaware
Decided May 9, 2019No. Civil Action No. 18-1953-CFCPublishedCited by 6 opinions
1Opinion of the Court
COLM F. CONNOLLY, UNITED STATES DISTRICT JUDGE
Plaintiff Eagle Pharmaceuticals, Inc. has sued Defendant Slayback Pharma LLC, alleging infringement under the doctrine of equivalents of four patents: U.S. Patent Nos. 9,265,831 (the "#831 patent"), 9,572,796 (the "#796 patent"), 9,572,797 (the "#797 patent"), and 10,010,533 (the "#533 patent"). See generally D.I. 1. Pending before me is Slayback's motion for judgment on the pleadings pursuant to Federal Rule of Civil Procedure 12(c). D.I. 14. The matter is fully briefed. D.I. 15, 20, 25. For the reasons discussed below, I will grant Slayback's…
2Cases cited16 opinions
- In Re Burlington Coat Factory Securities Litigation. P. Gregory Buchanan, Jacob Turner and Ronald AbramoffCourt of Appeals for the Third Circuit · 1997
- Graver Tank & Mfg. Co. v. Linde Air Products Co.Supreme Court of the United States · 1950
- Warner-Jenkinson Co. v. Hilton Davis Chemical Co.Supreme Court of the United States · 1997
- Sage Products, Inc. v. Devon Industries, Inc., Defendant/cross-AppellantCourt of Appeals for the Federal Circuit · 1997
- Multiform Desiccants, Inc., Plaintiff-Cross v. Medzam, Ltd.Court of Appeals for the Federal Circuit · 1998
11 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- Eagle Pharmaceuticals Inc. v. Slayback Pharma LLCCourt of Appeals for the Federal Circuit · 2020
- Eagle Pharmaceuticals, Inc. v. Hospira, Inc.District Court, D. Delaware · 2019
- Eagle Pharmaceuticals, Inc. v. Hospira, Inc.District Court, D. Delaware · 2019
- Novartis Pharmaceuticals Corporation v. MSN Pharmaceuticals Inc.District Court, D. Delaware · 2023
- Olink Proteomics AB v. Alamar Biosciences, Inc.District Court, D. Delaware · 2025
1 more not listed; retrieve them via the Exa API.